TRxADE Health Inc (MEDS) Noticias

MEDS to SCNX, 9/23/2024

Loving it. Biding it up for the div. Ex div drops it. Decide if you trading it or for the cash payout

Buy the pull back

Nobody else taking there MEDS $18.51 + 30%

MEDS $14.75 keep it coming

Meds + 30% $11.73 low floater good month of June

Take your MEDS today

MEDS 10Q due 3/27

#MEDS 🔥 breakingout this week? $meds

MEDS new 52 week hi

Buckle up my friend! $MEDS will be $HOLO on steroids next week!
Nano float that is LOCKED, and of all days , Friday showed INCREDIBLE STRENGTH when day and swing traders cash out!
Buckle up 5 point seatbelt harness, and place oxygen mask on!! We’re going SUPERSONIC $MEDS is next week!
I LOVE NANO FLOATS, $8 DIVIDEND per share, coupled with 20% float shorted!

SHORTS MUST COVER!
Grab your popcorn friend, we’re on the ROCKETSHIP RIDE this next week!
All my opinion, not financial advise!
BURN SHORTS!!!
Respectfully,
Maverick

Thanks my friend! I hope next week runs really big!

Almost 20% of the FLOAT is short!! Going to be a MASSIVE SHORT SQUEEZE all next week!
Volume proceeds price, and we had low volume day , went up $6 share and 20% float is short!

TIK TOK, see you all north of $50 next week as SHORTS MUST COVER, and PAY DIVIDEND if they don’t cover!
VOLUME comes in, this stock $MEDS will make $HALO look like a walk in the park!
$MEDS also has only 1/4 of the float as $HALO did , and with 20% float short, coupled with FLOAT LOCK, and $8 per share dividend coming MOTHER OF ALL SHORT SQUEEZES is inbound in my humble opinion!
$MEDS on supersonic speed as you can see the FLOAT LOCK with a $1 spread between bid and ask!
Premarket Monday and everyday next week will be SPECTACULAR in my opinion based on the above!
Management set “LONGS” up to be KINGS here and one of the MOST REPUTABLE law firms handled this transaction!
A+
Have super weekend friends and the smell in here is “shorts about to be fried” “deep fried” next week when this $MEDS pulls a SUPERSONIC $HOLO move on 1/4 of the float that $HOLO had!

$8 DIVIDEND COMING !
20% of a 830,000 float SHORTED
FLOAT LOCK
EVERYONE WILL be jumping in to get that dividend and PERFECT ROCKET right here folks will remember..
MEDS $MEDS

ALL my humble opinion, and not financial advise!

Short fry coming next week as shorts MUST COVER, plain, pure , simple!
Respectfully,
Maverick

Great video, nicely done! $MEDS MEDS, see you at $50 plus next week!

Shorts are desperate as they have to cover before the dividend; they will spread misinformation!
Shorts are responsible for covering and if they FAIL , they also have to pay the dividend!
This company set up “longs” with precision!

Keep up EXCELLENT WORK on your charts and videos!
This FLOAT IS LOCKED!
MOTHER OF ALL SHORT SQUEEZES IS COMING and I feel will give $MEDS MEDS a MASSIVE share price appreciation in my humble opinion!

Not financial advise!
GLTU!
Respectfully,
Maverick

#MEDS 🔥 watch for squeeze this week! $50 possible with volume $meds

Yes! $MEDS MEDS closed at 52 week high on FRIDAY! Going supersonic all the way to the dividend date!! GLTU!!
Respectfully,
Maverick

WOW $27 NEXT...

MEDS $MEDS Very nice stair stepping , coupled with a MOASS incoming with the $8 dividend per share by March 18, with payout March 22!

Riding this puppy since $12.46 and expecting $40-$60 plus share by dividend date!

Float is LOCKED!
Going to be on after burners up to dividend day!

All in my opinion, not financial advise!

Tiny float, and BIG folks accumulating via the charts!

Could pull a $HOLO HOLO price per share appreciation with 1/4 of the float HOLO $HOLO had!

Go MEDS $MEDS

MOTHER OF ALL SHORT SQUEEZES coming by dividend date in my humble opinion!

Respectfully
Maverick

The company is selling Trxade, Inc. assets for $22.5 million in cash.

https://www.globenewswire.com/news-release/2024/03/06/2841400/0/en/TRxADE-Health-Inc-Announces-Special-Cash-Dividend.html

? $8 DIVY

https://www.globenewswire.com/news-release/2024/03/06/2841400/0/en/TRxADE-Health-Inc-Announces-Special-Cash-Dividend.html
$MEDS TRxADE Health, Inc. Announces Special Cash Dividend Of $8/Share

Pop on this— AlertsAndNews (@AlertsAndNews) March 6, 2024

TRxADE Health, Inc. Announces Special Cash Dividend

how the 8k reads seems that person is right. all assets are being sold to MMX & company will operate under its own subsidiary.

Bravo all

one buy in chat said after this news all thats left is a SHELL

dunno if thats true

No big deal on the news. I sold too.

I sold for a profit but what do you make of the news

Awesome move today.

https://ih.advfn.com/stock-market/NASDAQ/trxade-health-MEDS/stock-news/93305511/form-8-k-current-report

https://investors.trxadegroup.com/trxd-press-releases/

8kout

BULLSHIT

MEDS had great news today. Should go higher next week, most probably in the teens by end of next week.

Looking for 22.00 and higher

15s blink of an eye

Something leak?

Trader, you could be right buddy!!

Looks like insiders are slowly accumulating SBES!! Another 10 million traded so far today.

Hopefully we'll hear something soon!!!

$$$$SBES

Heard some rumours Suren will be rolling his former pharma business from here, MEDS, over to SBES later. We'll see

Wash trading

what is float? I believe it's less than 700K. Why is it traded 4.8M+ when float is only 700K?

MEDS resumed up another buck

MEDS halted

MEDS will be No 1 on the Barchart Top 100 when the normal market opens

Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

This has been a great scalp play since r/s. Volatility...

Change of guards correct the situation.

THEN 12.80

THATS WHY I WAS BEARISH

JUST COULDNT SHORT IT

28 minutes later
21.85
14.85

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing



On June 23, 2023, the Listing Qualifications department of The Nasdaq Stock Market LLC (the “Nasdaq”) notified the Company that the Company was not in compliance with Nasdaq’s listing rules (the “Listing Rules”) as set forth in Listing Rule 5550(a)(4) given the Company’s failure to maintain a sufficient number of publicly held shares (the “Notice”). Citing the Company’s Event Form submitted to Nasdaq on June 7, 2023, Nasdaq calculated the Company’s publicly held shares as approximately 310,057 (which amount excludes shares held by officers, directors, or beneficial owners of 10 percent or more), on a post-split basis, effective as of June 22, 2023. To satisfy the requirement for continued listing on Nasdaq, the Company must maintain a minimum of 500,000 publicly held shares.



The Notice states that the Company has until August 7, 2023 to submit a plan to regain compliance with Listing Rule 5550(a)(4). If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel.



Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year



On June 26, 2023, the Company filed a Certificate of Designation, Preferences, Rights and Limitations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Certificate of Designation”). The Certificate of Designation provides for the issuance of shares of the Company’s Series B Preferred Stock, par value $0.00001 per share (the “Series B Preferred Stock”).



Pursuant to the Certificate of Designation, the Series B Preferred Stock is non-participating and shall receive no dividends, has no liquidation preference, has no voting rights, and has no redemption rights.



The Series B Preferred Stock is not convertible at the election of the holder. Upon approval of conversion by the Company’s stockholders, each outstanding share of Series B Preferred Stock (including any fraction of a share) shall automatically convert into 100 shares of the Company’s common stock, par value $0.00001 per share, without any further action by the relevant holder of such Series B Preferred Stock or the Company.



In the event that a merger, acquisition of reorganization of the Company or its subsidiary with Superlatus, Inc., as previously disclosed in the Current Report on Form 8-K filed by the Company on June 23, 2023 does not close before December 31, 2023, the Company will repurchase all of the shares of Series B Preferred Stock for the price originally paid by each holder for the Series B Preferred Stock.



The foregoing description of the Certificate of Designation is a summary and is qualified in its entirety by the terms of the Certificate of Designation filed with the Secretary of State of the State of Delaware, which is attached hereto as Exhibit 3.1 and incorporated herein by reference.



Item 9.01. Financial Statements and Exhibits



Exhibit No. Description of Exhibit
3.1 Certificate of Designation of Series B Preferred Stock
104 Inline XBRL for the cover page of this Current Report on Form 8-K

Nice

Icahn or some dog is loading in $MEDS $20+ come Monday